title: Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
authors.affiliation: Department of Dermatology, Ajou University School of Medicine, 164 World Cup-ro, Yeongtong-gu, Suwon 443-380, South Korea.
authors.forename: Young Joon
authors.initials: YJ
authors.lastname: Park
authors.affiliation: Department of Dermatology, Ajou University School of Medicine, 164 World Cup-ro, Yeongtong-gu, Suwon 443-380, South Korea.
authors.forename: Byoung Woo
authors.initials: BW
authors.lastname: Soh
authors.affiliation: Department of Dermatology, Ajou University School of Medicine, 164 World Cup-ro, Yeongtong-gu, Suwon 443-380, South Korea.
authors.forename: Eun-So
authors.initials: ES
authors.lastname: Lee
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D005533:Foot Dermatoses / Q000139:chemically induced* / Q000473:pathology; D006229:Hand Dermatoses / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007911:Lentigo / Q000139:chemically induced*; D008297:Male; D010094:Oxonic Acid / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects; D005641:Tegafur / Q000009:adverse effects
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D011725:Pyridines; D005641:Tegafur; D010094:Oxonic Acid; C104201:gimeracil